Graybug Vision enters $2M bridge loan with CalciMedica and amends merger terms

CalciMedica, Inc.

Graybug agrees to lend CalciMedica up to $2M at 7.5% annual interest; initial $500K advanced.
Amendment ensures outstanding loan principal and interest included in Graybug's net cash for merger closing.
CalciMedica must use proceeds for payroll, rent, clinical trial, and regulatory costs; additional draws require Graybug approval.
Merger termination triggers mandatory prepayment or credit against termination fees; three-month maturity after anniversary.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CalciMedica, Inc. entered into Note Purchase Agreement with Graybug Vision, Inc. valued at $2.0 million (effective 2023-02-10).

Action: entry
Agreement: notes offering
Counterparty: Graybug Vision, Inc.
Value: $2.0 million
Effective: 2023-02-10

Exact text from the filing

On February 10, 2023, Graybug Vision, Inc. (“Graybug”) and CalciMedica, Inc. (“CalciMedica”) entered into a note purchase agreement (the “Note Purchase Agreement”) providing for Graybug to make short-term loans (the “Loan” or “Loans”) to CalciMedica up to an aggregate principal amount of $2.0 million

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CalciMedica, Inc. amended First Amendment with Graybug, CalciMedica and Camaro Merger Sub, Inc. (effective 2023-02-10).

Action: amendment
Agreement: merger
Counterparty: Graybug, CalciMedica and Camaro Merger Sub, Inc.
Effective: 2023-02-10

Exact text from the filing

In connection with the Note Purchase Agreement, on February 10, 2023, Graybug, CalciMedica and Camaro Merger Sub, Inc. (“Camaro Merger Sub”) entered into a First Amendment (the “Amendment”) to the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”)

View on SEC.gov

623 material agreements filed in the last 30 days. Browse all material agreements →

CalciMedica, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-041092

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.